- Home
- / Wren Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Wren Therapeutics financials data including stock price, CreditSafe score, and balance sheet.
Total Funding
$23.3 M
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2017 | FY, 2018 |
|---|---|---|
| Cash | 518.0K | 18.3M |
| Accounts Receivable | 15.0K | |
| Current Assets | 2.0M | 18.6M |
| PP&E | 273.0K | 282.0K |
| Total Assets | 2.3M | 18.9M |
| Accounts Payable | 161.0K | 136.0K |
| Current Liabilities | 344.0K | 547.0K |
| Short-term Debt | 51.0K | |
| Total Debt | 51.0K | |
| Total Liabilities | 344.0K | 547.0K |
| Common Stock | 1.0K | 1.0K |
| Retained Earnings | (1.2M) | (2.9M) |
| Total Equity | 2.0M | 18.4M |
| Financial Leverage | 1.2 | 1 |